| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |